Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

TLR4, TRIF, and MyD88 are essential for myelopoiesis and CD11c + adipose tissue macrophage production in obese mice.

Griffin C., Eter L., Lanzetta N., Abrishami S., Varghese M., McKernan K.

Animal Study on Type 2 Diabetes, Chronic Inflammation, published in J Biol Chem (2018) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
J Biol Chem (2018)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
29636416
PMCID
PMC5995515
DOI
10.1074/jbc.RA117.001526
Citations
66

Abstract (original English)

Obesity-induced chronic inflammation is associated with metabolic disease. Results from mouse models utilizing a high-fat diet (HFD) have indicated that an increase in activated macrophages, including CD11c + adipose tissue macrophages (ATMs), contributes to insulin resistance. Obesity primes myeloid cell production from hematopoietic stem cells (HSCs) and Toll-like receptor 4 (TLR4), and the downstream TIR domain-containing adapter protein-inducing interferon-β (TRIF)- and MyD88-mediated pathways regulate production of similar myeloid cells after lipopolysaccharide stimulation. However, the role of these pathways in HFD-induced myelopoiesis is unknown. We hypothesized that saturated fatty acids and HFD alter myelopoiesis by activating TLR4 pathways in HSCs, differentially producing pro-inflammatory CD11c + myeloid cells that contribute to obesity-induced metabolic disease. Results from reciprocal bone marrow transplants (BMTs) with Tlr4 -/- and WT mice indicated that TLR4 is required for HFD-induced myelopoiesis and production of CD11c + ATMs. Experiments with homozygous knockouts of Irakm (encoding a suppressor of MyD88 inactivation) and Trif in competitive BMTs revealed that MyD88 is required for HFD expansion of granulocyte macrophage progenitors and that Trif is required for pregranulocyte macrophage progenitor expansion. A comparison of WT, Tlr4 -/- , Myd88 -/- , and Trif

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adaptor Proteins, Vesicular TransportAdipose TissueAnimalsCD11c AntigenDiet, High-FatInflammationMacrophagesMaleMice, Inbred C57BLMice, Obese

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research